Search Results 61-70 of 18650 for Parkinson's disease
The Neurobiology of Parkinson's Disease Lab seeks to determine if excess toxic intermediate species of alpha-synuclein can lead to proteasome dysfunction.
Health care professionals can't diagnose Parkinson's disease until you have symptoms, which include shaking and slowed movement. But in the research setting, an ...
Cytoplasmic deposition of alpha-synuclein aggregates is a common pathological feature of many neurodegenerative synucleinopathies, including Parkinson's disease ...
Mayo Clinic's Parkinson's Disease Lab in Florida under the direction of Owen Ross, Ph.D., studies the genetic factors involved in Parkinson's disease.
... and may mimic those of Parkinson's disease and dementia. Symptoms get worse over time and may include: Stiffness, especially of the neck, and awkward movements.
Results of a new Mayo Clinic study support an association between anemia experienced early in life and the development of Parkinson's disease many years later.
... and the ability to smell things in patients with Parkinson disease and ... and stride reduction in patients with Parkinson's disease and Parkinsonism.
The Parkinson Progression Marker Initiative (PPMI) is a study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic ...
... and/or genetic factors predict survival, and other outcomes (e.g., dementia, hallucinations, wheelchair use) in Parkinson's disease (PD)?". Participation ...
ROCHESTER, Minn. — People with the movement disorder Parkinson's disease have a much higher risk of the skin cancer melanoma, and vice versa, a Mayo Clinic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.